Clinical Trial Update: Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS

View source ↗

Summary

A clinical trial evaluating biomarkers to reduce antibiotic use in newborns with suspected infection (neonatal late-onset sepsis) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Late-onset Sepsis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Neonatal Late Onset Sepsis | Status: RECRUITING